Fulgent Genetics
FLGT
298 hedge funds and large institutions have $1.13B invested in Fulgent Genetics in 2021 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 106 increasing their positions, 76 reducing their positions, and 28 closing their positions.
118% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 28
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
39% more repeat investments, than reductions
Existing positions increased: 106 | Existing positions reduced: 76
11% more funds holding
Funds holding: 268 → 298 (+30)
10% more capital invested
Capital invested by funds: $1.02B → $1.13B (+$107M)
0.87% less ownership
Funds ownership: 38.56% → 37.69% (-0.87%)
5% less call options, than puts
Call options by funds: $60.4M | Put options by funds: $63.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$22.7M |
| 2 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$7.01M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$5.09M |
| 4 |
BlackRock
New York
|
+$4.46M |
| 5 |
Bank of New York Mellon
New York
|
+$3.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$34.7M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$17.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$15.8M |
| 4 |
NI
Nepsis Inc
Minneapolis,
Minnesota
|
-$8.76M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.13M |
FLGT Hedge Fund Activity: Q4 2021 in Review
298 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2021, worth a combined $1.13B — up 10% from $1.02B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new FLGT positions and 28 closed out — a net gain of 33 holders — while 106 added to existing stakes and 76 trimmed.
The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $22.7M. The largest seller was JP Morgan Chase, cutting an estimated $34.7M.
- 298 institutional investors held Fulgent Genetics (FLGT) as of Q4 2021, up from 268 in Q3 2021.
- Funds reported $1.13B of Fulgent Genetics stock for Q4 2021, up 10% quarter-over-quarter.
- 61 funds opened new Fulgent Genetics positions in Q4 2021 and 28 closed out, a net change of +33 holders.
- The largest Fulgent Genetics buyer in Q4 2021 was Skandinaviska Enskilda Banken (SEB), an estimated $22.7M added.
- The largest Fulgent Genetics seller in Q4 2021 was JP Morgan Chase, an estimated $34.7M sold.
Based on aggregated 13F filings for Q4 2021.